Literature DB >> 10026356

QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion.

C E Bonnar1, A P Davie, L Caruana, L Fenn, S A Ogston, J J McMurray, A D Struthers.   

Abstract

OBJECTIVE: To compare QT dispersion in patients with impaired left ventricular systolic function and in matched control patients with normal left ventricular systolic function.
DESIGN: A retrospective, case-control study with controls matched 4:1 for age, sex, previous myocardial infarction, and diuretic and beta blocker treatment.
SETTING: A regional cardiology centre and a university teaching hospital. PATIENTS: 25 patients with impaired left ventricular systolic function and 100 patients with normal left ventricular systolic function. MAIN OUTCOME MEASURES: QT and QTc dispersion measured by three methods: the difference between maximum and minimum QT and QTc intervals, the standard deviation of QT and QTc intervals, and the "lead adjusted" QT and QTc dispersion.
RESULTS: All measures of QT/QTc dispersion were closely interrelated (r values 0.86 to 0.99; all p < 0.001). All measures of QT and QTc dispersion were significantly increased in the patients with impaired left ventricular systolic function v controls (p < 0.001): 71.9 (6.5) (mean (SEM)) v 46.9 (1.7) ms for QT dispersion, and 83.6 (7.6) v 54.3 (2.1) ms(-1-2) for QTc dispersion. All six dispersion parameters were reduced in patients taking beta blockers (p < 0.05), regardless of whether left ventricular function was normal or impaired-by 9.4 (4.6) ms for QT dispersion (p < 0.05) and by 13.8 (6. 5) ms(-1-2) for QTc dispersion (p = 0.01).
CONCLUSIONS: QT and QTc dispersion are increased in patients with systolic heart failure in comparison with matched controls, regardless of the method of measurement and independently of possible confounding factors. beta Blockers are associated with a reduction in both QT and QTc dispersion, raising the possibility that a reduction in dispersion of ventricular repolarisation may be an important antiarrhythmic mechanism of beta blockade.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026356      PMCID: PMC1728970          DOI: 10.1136/hrt.81.3.297

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  31 in total

1.  Left ventricular hypertrophy and QT dispersion in hypertension.

Authors:  J Mayet; M Shahi; K McGrath; N R Poulter; P S Sever; R A Foale; S A Thom
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

2.  Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease.

Authors:  C S Barr; A A Naas; M Fenwick; A D Struthers
Journal:  Am J Cardiol       Date:  1997-02-01       Impact factor: 2.778

3.  Reproducibility and automatic measurement of QT dispersion.

Authors:  J M Glancy; P J Weston; H K Bhullar; C J Garratt; K L Woods; D P de Bono
Journal:  Eur Heart J       Date:  1996-07       Impact factor: 29.983

4.  Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function.

Authors:  G S Fu; A Meissner; R Simon
Journal:  Eur Heart J       Date:  1997-02       Impact factor: 29.983

5.  Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.

Authors:  A P Davie; C M Francis; M P Love; L Caruana; I R Starkey; T R Shaw; G R Sutherland; J J McMurray
Journal:  BMJ       Date:  1996-01-27

6.  QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy.

Authors:  W Grimm; U Steder; V Menz; J Hoffman; B Maisch
Journal:  Am J Cardiol       Date:  1996-08-15       Impact factor: 2.778

7.  QT dispersion and mortality after myocardial infarction.

Authors:  J M Glancy; C J Garratt; K L Woods; D P de Bono
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

8.  Open access echocardiography in management of heart failure in the community.

Authors:  C M Francis; L Caruana; P Kearney; M Love; G R Sutherland; I R Starkey; T R Shaw; J J McMurray
Journal:  BMJ       Date:  1995-03-11

9.  Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction.

Authors:  J S Perkiömäki; M J Koistinen; S Yli-Mäyry; H V Huikuri
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

10.  Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease.

Authors:  D Darbar; J Luck; N Davidson; T Pringle; G Main; G McNeill; A D Struthers
Journal:  BMJ       Date:  1996-04-06
View more
  10 in total

1.  Circadian variation in QT dispersion determined from a 12-lead Holter recording: a methodological study of an age- and sex-stratified group of healthy subjects.

Authors:  Stig Hansen; Verner Rasmussen; Klaus Larsen; Christian Torp-Pedersen; Gorm Boje Jensen
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

2.  Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure.

Authors:  P Milberg; M Fink; C Pott; G Frommeyer; J Biertz; N Osada; J Stypmann; G Mönnig; M Koopmann; G Breithardt; L Eckardt
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Heart-rate recovery index is impaired in Behçet's disease.

Authors:  Ergun Baris Kaya; Hikmet Yorgun; Ali Akdogan; Ahmet Hakan Ates; Ugur Canpolat; Hamza Sunman; Kudret Aytemir; Lale Tokgozoglu; Giray Kabakci; Meral Calguneri; Hilmi Ozkutlu; Ali Oto
Journal:  Tex Heart Inst J       Date:  2009

4.  QT intervals and QT dispersion determined from a 12-lead 24-hour Holter recording in patients with coronary artery disease and patients with heart failure.

Authors:  Stig Hansen; Verner Rasmussen; Christian Torp-Pedersen; Gorm Boje Jensen
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-01       Impact factor: 1.468

5.  Effects of metoprolol on QT interval and QT dispersion in Type 1 diabetic patients with abnormal albuminuria.

Authors:  E Ebbehøj; H Arildsen; K W Hansen; C E Mogensen; H Mølgaard; P L Poulsen
Journal:  Diabetologia       Date:  2004-06-08       Impact factor: 10.122

6.  Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.

Authors:  Anna Kezerashvili; Himad Khattak; Aron Barsky; Reza Nazari; John D Fisher
Journal:  J Interv Card Electrophysiol       Date:  2007-06-02       Impact factor: 1.900

7.  Nebivolol therapy improves QTc and QTcd parameters in heart failure patients.

Authors:  S M Aksoy; S Cay; G Cagirci; N Sen
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

8.  Survey of the effect of streptokinase on ventricular repolarization by examining the QT dispersion in patients with acute myocardial infraction in Seyed-Al-Shohada hospital, Urmia.

Authors:  B Rahimi Darabad; J Vatandust; M M Pourmousavi Khoshknab; M H Seyed Mohammad Zad
Journal:  Glob J Health Sci       Date:  2014-09-18

9.  QT Dispersion and Drug-Induced Torsade de Pointes.

Authors:  Ari Friedman; Jeremy Miles; Jared Liebelt; Panagiota Christia; Krysthel Engstrom; Rosy Thachil; Michael Grushko; Robert T Faillace
Journal:  Cureus       Date:  2021-01-25

10.  Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.

Authors:  Mehmet Burhan Oflaz; Sevket Balli; Ayse Esin Kibar; Ibrahim Ece; Celal Akdeniz; Volkan Tuzcu
Journal:  Med Sci Monit       Date:  2013-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.